Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Brasileira de Farmacognosia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2009000100003 |
Resumo: | This study examined the effect of trans-dehydrocrotonin (DCTN), a 19-nor-clerodane diterpene isolated from Croton cajucara Benth (Euphorbiaceae), as analgesic and its effect on the central nervous system (CNS) of rodents using different animal models. The DCTN intraperitoneally exhibited mild analgesic activity on hot-plate test, but exhibited strong antinociceptive activity against acetic acid-induced abdominal writhing and the ED50 was calculated to be 44.88 mg/kg. At higher doses (100 mg/kg) it exhibited mild CNS depressant activities in laboratory animals. Moreover, it has negligible antidepressant activity. After taking consideration of the drug interaction, the DCTN can be used as a potent analgesic agent in case of peripheral algesia, without affecting the CNS. |
id |
SBFGNOSIA-1_da44c4e5bb7fd8695f7354d83871f12a |
---|---|
oai_identifier_str |
oai:scielo:S0102-695X2009000100003 |
network_acronym_str |
SBFGNOSIA-1 |
network_name_str |
Revista Brasileira de Farmacognosia (Online) |
repository_id_str |
|
spelling |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous systemCroton cajucaraEuphorbiaceaetrans-dehydrocrotonincentral nervous systemThis study examined the effect of trans-dehydrocrotonin (DCTN), a 19-nor-clerodane diterpene isolated from Croton cajucara Benth (Euphorbiaceae), as analgesic and its effect on the central nervous system (CNS) of rodents using different animal models. The DCTN intraperitoneally exhibited mild analgesic activity on hot-plate test, but exhibited strong antinociceptive activity against acetic acid-induced abdominal writhing and the ED50 was calculated to be 44.88 mg/kg. At higher doses (100 mg/kg) it exhibited mild CNS depressant activities in laboratory animals. Moreover, it has negligible antidepressant activity. After taking consideration of the drug interaction, the DCTN can be used as a potent analgesic agent in case of peripheral algesia, without affecting the CNS.Sociedade Brasileira de Farmacognosia2009-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2009000100003Revista Brasileira de Farmacognosia v.19 n.1a 2009reponame:Revista Brasileira de Farmacognosia (Online)instname:Sociedade Brasileira de Farmacognosia (SBFgnosia)instacron:SBFGNOSIA10.1590/S0102-695X2009000100003info:eu-repo/semantics/openAccessKhan,Mahmud T. H.Ather,ArjumandPinto,Angelo C.Maciel,Maria Aparecida M.eng2009-08-11T00:00:00Zoai:scielo:S0102-695X2009000100003Revistahttp://www.sbfgnosia.org.br/revista/https://old.scielo.br/oai/scielo-oai.phprbgnosia@ltf.ufpb.br1981-528X0102-695Xopendoar:2009-08-11T00:00Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia)false |
dc.title.none.fl_str_mv |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system |
title |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system |
spellingShingle |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system Khan,Mahmud T. H. Croton cajucara Euphorbiaceae trans-dehydrocrotonin central nervous system |
title_short |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system |
title_full |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system |
title_fullStr |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system |
title_full_unstemmed |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system |
title_sort |
Potential benefits of the 19-nor-clerodane trans-dehydrocrotonin on the central nervous system |
author |
Khan,Mahmud T. H. |
author_facet |
Khan,Mahmud T. H. Ather,Arjumand Pinto,Angelo C. Maciel,Maria Aparecida M. |
author_role |
author |
author2 |
Ather,Arjumand Pinto,Angelo C. Maciel,Maria Aparecida M. |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Khan,Mahmud T. H. Ather,Arjumand Pinto,Angelo C. Maciel,Maria Aparecida M. |
dc.subject.por.fl_str_mv |
Croton cajucara Euphorbiaceae trans-dehydrocrotonin central nervous system |
topic |
Croton cajucara Euphorbiaceae trans-dehydrocrotonin central nervous system |
description |
This study examined the effect of trans-dehydrocrotonin (DCTN), a 19-nor-clerodane diterpene isolated from Croton cajucara Benth (Euphorbiaceae), as analgesic and its effect on the central nervous system (CNS) of rodents using different animal models. The DCTN intraperitoneally exhibited mild analgesic activity on hot-plate test, but exhibited strong antinociceptive activity against acetic acid-induced abdominal writhing and the ED50 was calculated to be 44.88 mg/kg. At higher doses (100 mg/kg) it exhibited mild CNS depressant activities in laboratory animals. Moreover, it has negligible antidepressant activity. After taking consideration of the drug interaction, the DCTN can be used as a potent analgesic agent in case of peripheral algesia, without affecting the CNS. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-03-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2009000100003 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2009000100003 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0102-695X2009000100003 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Farmacognosia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Farmacognosia |
dc.source.none.fl_str_mv |
Revista Brasileira de Farmacognosia v.19 n.1a 2009 reponame:Revista Brasileira de Farmacognosia (Online) instname:Sociedade Brasileira de Farmacognosia (SBFgnosia) instacron:SBFGNOSIA |
instname_str |
Sociedade Brasileira de Farmacognosia (SBFgnosia) |
instacron_str |
SBFGNOSIA |
institution |
SBFGNOSIA |
reponame_str |
Revista Brasileira de Farmacognosia (Online) |
collection |
Revista Brasileira de Farmacognosia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia) |
repository.mail.fl_str_mv |
rbgnosia@ltf.ufpb.br |
_version_ |
1752122463380045824 |